Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis,Expert Review of Clinical Immunology

当前位置： X-MOL 学术 › Expert Rev. Clin. Immunol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2024-03-06 , DOI: 10.1080/1744666x.2024.2324005
Jinge Huang ₁ , Qingmiao Zhu ₂ , Baizhou Wang ₁ , Hanzheng Wang ₁ , Zhijun Xie ₂ , Xingyu Zhu ₃ , Ting Zhao ₂ , Zi Yang _{4,

5}

Affiliation

This article aims to evaluate the magnitude of adverse pregnancy outcomes (APOs) risks associated with different antiphospholipid antibody (aPL) profiles in women with systemic lupus erythematosus ...

中文翻译：